HeartBeam Issued Cardiac Detection Patent for HeartBeam AIMIGo System

(24/7 MARKET NEWS) – HeartBeam, Inc. (NASDAQ: BEAT) stated, this morning, it received a notice of allowance from The United States Patent and Trademark Office for a key patent relating to the initial AI capability in the form of an expert system for its HeartBeam AIMIGo System.

HeartBeam is trading at $2.40, up $0.37 (+19.10%), on 712K premarket shares traded.Its 52-week range is $1.12 to $6.74. It’s traded sideways for the past three months, so, if its trading volume increases, this could try to make a run to the $3+ level.24/7 MARKET NEWS, INC Disclaimer24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make. Please go to or for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist